Browsing by Author "Kalayci, Ö"

Now showing 1 - 5 of 5
  • No Thumbnail Available
    Item
    Allergic rhinitis and its impact on asthma update (ARIA 2008) The Turkish perspective
    Yorgancioglu, A; Kalayci, Ö; Kalyoncu, AF; Khaltaev, N; Bousquet, J
    In this article, it is aimed to summarize the newly updated and published version of Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 and add the recent Turkish epidemiological data on it.
  • No Thumbnail Available
    Item
    ARIA (Allergic rhinitis and its impact on asthma) Achievements in 10 years and future needs
    Yorgancioglu, A; Özdemir, C; Kalayci, Ö; Kalyoncu, AF; Bachert, C; Baena-Cagnani, CE; Casale, TB; Chen, YZ; Cruz, AA; Demoly, P; Fokkens, WJ; Carlsen, KCL; Mohammad, Y; Mullol, J; Ohta, K; Papadopoulos, NG; Pawankar, R; Samolinski, B; Schüemann, HJ; Yusuf, OM; Zuberbier, T; Bousquet, J
    Allergic rhinitis and asthma represent global health problems for all age groups. Asthma and rhinitis frequently co-exist in the same subjects. Allergic Rhinitis and its Impact on Asthma (ARIA) was initiated during a World Health Organization (WHO) workshop in 1999 and was published in 2001. ARIA has reclassified allergic rhinitis as mild/moderate-severe and intermittent/persistent. This classification schema closely reflects the impact of allergic rhinitis on patients. In its 2010 Revision, ARIA developed clinical practice guidelines for the management of allergic rhinitis and asthma co-morbidities based on GRADE (Grading of Recommendation, Assessment, Development and Evaluation). ARIA has been disseminated and implemented in over 50 countries of the world. In Turkey, it is important to make a record of ARIA achievements and to identify the still unmet clinical, research and implementation needs in order to strengthen the 2011 EU Priority on allergy and asthma in children.
  • No Thumbnail Available
    Item
    2019 ARIA Care Pathways for Allergic Rhinitis-Turkey
    Yorgancioglu, AA; Gemicioglu, B; Cingi, C; Kalayci, Ö; Kalyoncu, AF; Bachert, C; Hellings, P; Pfaar, O; Schünemann, HJ; Wallace, D; Bedbrook, A; Czarlewski, W; Bousquet, J
    The evaluation of real-life integrated care pathways (ICPs) was recommended for digitally enabled, integrated, person-centered care for rhinitis and asthma multimorbidity embedding environmental exposure. ICPs are structured multidisciplinary care plans detailing key steps of patient care. They promote the translation of guideline recommendations into local protocols and their application to clinical practice. In allergic rhinitis, there is an urgent need to develop next-generation guidelines for pharmacotherapy and ICPs for allergen immunotherapy. A meeting was held in Paris on December 3, 2018, during which two separate documents were produced. An executive summary is presented in this article, which will be customized in different countries or regions in order to adjust the conclusions of the papers for local use and health systems.
  • No Thumbnail Available
    Item
    ARIA 2016 executive summary: integrated care pathways for predictive medicine across the life cycle
    Yorgancioglu, AA; Kalayci, Ö; Cingi, C; Gemicioglu, B; Kalyoncu, AF; Agache, I; Bachert, C; Bedbrook, A; Canonica, GW; Casale, T; Cruz, A; Fokkens, WEJ; Hellings, P; Samolinski, B; Bousquet, J
    The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization (WHO) workshop in 1999. The initial goals were (i) to propose a new allergic rhinitis classification, (ii) to promote the concept of multi-morbidity in asthma and rhinitis and (iii) to develop guidelines with all stakeholders for global use in all countries and populations. ARIA-disseminated and implemented in over 70 countries globally-is now focusing on the implementation of emerging technologies for individualized and predictive medicine. MASK (MACVIA (Contre les MAladies Chroniques pour un VIeillissement Actif)-ARIA Sentinel NetworK) uses mobile technology to develop care pathways in order to enable the management of rhinitis and asthma by a multi-disciplinary group or by patients themselves. An App (Android and iOS) is available in 20 countries and 15 languages. It uses a visual analogue scale to assess symptom control and work productivity as well as a clinical decision support system. It is associated with an inter-operable tablet for physicians and other health care professionals. The scaling up strategy uses the recommendations of the European Innovation Partnership on Active and Healthy Ageing. The aim of the novel ARIA approach is to provide an active and healthy life to rhinitis sufferers, whatever their age, sex or socio-economic status, in order to reduce health and social inequalities incurred by the disease.
  • No Thumbnail Available
    Item
    Allergic rhinitis and its impact on asthma update (ARIA 2008): the Turkish perspective
    Kalayci, Ö; Yorgancioglu, A; Kalyoncu, AF; Khaltaev, N; Bousquet, J